Following the earnings reports, Nuance officials announced a projected net income between $1.05 and $1.15 per share and revenue between $2.03 billion and $2.09 billion in FY 2014. Analysts had been expecting projected earnings of $1.41 per share on revenue of $2.08 billion, according to a report in The Street.
Nuance officials blamed the lower projections on the company’s move from up-front licenses to subscription-based sales, according to the report.
“We are embracing this transition despite its effect on near-term revenues because our customers are demanding it and because we value the recurring nature, predictability and longevity of these revenue streams,” said CEO Paul Ricci, according to the report.
More Articles on the Health IT Market:
CareFusion Acquires GE Healthcare’s Vital Signs Division for $500M
Allscripts Reports 3Q Loss
Experian Acquires Passport Health Communications for $850M
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
